Metformin is associated with favorable outcomes in patients with COVID-19 and type 2 diabetes mellitus
Crossref DOI link: https://doi.org/10.1038/s41598-022-09639-2
Published Online: 2022-04-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ma, Zhiyuan
Patel, Nishit
Vemparala, Pranathi
Krishnamurthy, Mahesh
Text and Data Mining valid from 2022-04-01
Version of Record valid from 2022-04-01
Article History
Received: 21 September 2021
Accepted: 25 March 2022
First Online: 1 April 2022
Competing interests
: The authors declare no competing interests.